Identified lung adenocarcinoma metabolic phenotypes and their association with tumor immune microenvironment

Wu, XN; Su, D; Mei, YD; Xu, MQ; Zhang, H; Wang, ZY; Li, LL; Peng, L; Jiang, JY; Yang, JY; Li, DJ; Cao, H; Xia, ZW; Zeng, WJ; Cheng, Q; Zhang, N

Cheng, Q (corresponding author), Cent South Univ, Xiangya Hosp, Dept Neurosurg, Changsha 410008, Peoples R China.; Zhang, N (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, One Third Lab, Harbin 150000, Heilongjiang, Peoples R China.; Cheng, Q (corresponding author), Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha, Peoples R China.; Cheng, Q (corresponding author), Cent South Univ, Xiangya Hosp, Dept Clin Pharmacol, Changsha, Peoples R China.

CANCER IMMUNOLOGY IMMUNOTHERAPY, ; ():

Abstract

Background Lung adenocarcinoma (LUAD), a subtype of non-small cell lung cancer (NSCLC), causes high mortality around the world. Previous studies have ......

Full Text Link